About Ngl Fine-Chem Limited
Data last updated: 23 December 2025
Ngl Fine-Chem Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in animal pharmaceuticals and healthcare, a part of the broader pharmaceuticals sector. Incorporated on 18 December 1981, the company has been in operation for over 45 years.
Registered with ROC Mumbai under CIN L24110MH1981PLC025884. Listed on BSE: 524774.
Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.09 Cr. Formerly known as Angel Organic Chemicals Pvt Ltd and Angel Organic Chemicals Ltd. It is led by directors including Ajita Rahul Nachane and Dhananjay Narendra Mungale.
Last AGM: 19 August 2025. Financial statements filed for year ended 31 March 2025. Office: 301 E Square Subhash Road Vile Parle (East), Mumbai, Maharashtra, India – 400057.
As per the financials filed for FY 2025, the company reported a revenue of ₹376.89 Cr, a growth of 7% compared to the previous year.
The company has a workforce of approximately 363 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Ngl Fine Chem. As per MCA filings, the company has open charges of ₹117.75 Cr and satisfied charges of ₹53.89 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nglfinechem.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address301 E Square Subhash Road Vile Parle (East), Mumbai, Maharashtra, India – 400057
-
IndustryPharma, Animal Pharmaceuticals & Healthcare, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Ngl Fine-Chem Limited
Ngl Fine-Chem Limited has undergone 2 name changes throughout its history. The company was previously known as Angel Organic Chemicals Pvt Ltd, and Angel Organic Chemicals Ltd. The current legal name is Ngl Fine-Chem Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Ngl Fine-Chem Limited | Current |
| Angel Organic Chemicals Pvt Ltd | Previous |
| Angel Organic Chemicals Ltd | Previous |
CIN History of Ngl Fine-Chem Limited
Ngl Fine-Chem Limited has one previous CIN (Corporate Identification Number): U24110MH1981PTC025884. The current CIN is L24110MH1981PLC025884, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24110MH1981PLC025884 | Current |
| U24110MH1981PTC025884 | Previous |
Associated Brands with Ngl Fine-Chem Limited
Ngl Fine-Chem Limited operates one associated brand: NGL Fine Chem. These brands represent Ngl Fine-Chem Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals | nglfinechem.com |
Competitors & Alternatives of Ngl Fine-Chem Limited
Brands and companies operating in the same space as Ngl Fine-Chem Limited include Laurus Labs, Symbiotec, Sterling Pharma Solutions and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Apicore
|
APIs are manufactured and custom synthesis services are provided. | Somerset, United States, United States | 2004 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Bellen Chemistry
|
APIs and intermediates are researched and manufactured, specializing in heterocycles. | Beijing, China, China | 2007 |
Business Activity of Ngl Fine-Chem Limited
Ngl Fine-Chem Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Ngl Fine-Chem Limited
Ngl Fine-Chem Limited is audited by M/s. Manek & Associates (ICAI peer reviewed, certificate valid till 2029-01-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s. Manek & Associates (ICAI peer reviewed, certificate valid till 2029-01-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Ngl Fine-Chem Limited
Ngl Fine-Chem Limited is currently managed by 7 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ajita Rahul Nachane
Also directs:
Tele Access E-Services Private Limited
|
Director | 15 Sep 2014 | 11 Years 9 Months | Current |
|
Dhananjay Narendra Mungale
Also directs:
Kalpataru Projects International Limited, Lichfl Asset Management Company Limited, Dsp Asset Managers Private Limited and 3 more
|
Director | 18 Mar 2024 | 2 Years 3 Months | Current |
|
Rahul Jayant Nachane
Also directs:
Macrotech Polychem Private Limited, Nupur Remedies Pvt Ltd, Vetfar Pharmaceuticals Private Limited and 1 more
|
Managing Director | 04 Jan 1993 | 33 Years 6 Months | Current |
|
Sudhir Ramchandra Deo
Also directs:
Navin Fluorine International Limited
|
Director | 22 May 2025 | 1 Years 1 Months | Current |
|
Sarala Menon
Also directs:
Aretian Business Consulting Llp
|
Director | 14 Dec 2021 | 4 Years 6 Months | Current |
| Rajesh Narayan Lawande | Whole-Time Director | 01 Jun 2015 | 11 Years 1 Months | Current |
Financials of Ngl Fine-Chem Limited FY 2026 filings available
Ngl Fine-Chem Limited reported revenue of ₹500.95 Cr (up 36.03% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹500.95 Cr | ₹368.26 Cr | ₹338.69 Cr | ₹278.08 Cr |
| Other Income | ₹14.73 Cr | ₹8.63 Cr | ₹14.13 Cr | ₹5.53 Cr |
| Total Income | ₹515.68 Cr | ₹376.89 Cr | ₹352.82 Cr | ₹283.61 Cr |
| Cost of Materials Consumed | ₹247.22 Cr | ₹182.41 Cr | ₹170.81 Cr | ₹116.41 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹7.73 Cr | -₹59,000 | -₹12.13 Cr | ₹23.91 Cr |
| Employee Benefit Expense | ₹65.5 Cr | ₹55.55 Cr | ₹45.12 Cr | ₹36.87 Cr |
| Finance Costs | ₹4.47 Cr | ₹2.33 Cr | ₹1.34 Cr | ₹1.2 Cr |
| Depreciation & Amortisation | ₹19.58 Cr | ₹12.45 Cr | ₹11.64 Cr | ₹11.29 Cr |
| Other Expenses | ₹123.27 Cr | ₹96.43 Cr | ₹81.62 Cr | ₹66.57 Cr |
| Total Expenses | ₹452.32 Cr | ₹349.17 Cr | ₹298.4 Cr | ₹256.25 Cr |
| Profit Before Exceptional Items & Tax | ₹63.37 Cr | ₹27.71 Cr | ₹54.42 Cr | ₹27.36 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹63.37 Cr | ₹27.71 Cr | ₹54.42 Cr | ₹27.36 Cr |
| Total Tax Expense | ₹15.24 Cr | ₹6.59 Cr | ₹13.1 Cr | ₹6.87 Cr |
| Net Profit | ₹48.13 Cr | ₹21.12 Cr | ₹41.32 Cr | ₹20.5 Cr |
| attributable to Owners | ₹0 | - | ₹0 | ₹0 |
| attributable to NCI | ₹0 | - | ₹0 | ₹0 |
| Other Comprehensive Income | -₹24.23 Lakh | -₹24.04 Lakh | -₹15.28 Lakh | -₹8.4 Lakh |
| Total Comprehensive Income | ₹47.88 Cr | ₹20.88 Cr | ₹41.16 Cr | ₹20.41 Cr |
| EBITDA (computed) | ₹87.42 Cr | ₹42.5 Cr | ₹67.4 Cr | ₹39.85 Cr |
| Basic EPS | ₹77.90 | ₹34.19 | ₹66.88 | ₹33.18 |
| Diluted EPS | ₹77.90 | ₹34.19 | ₹66.88 | ₹33.18 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹545.5 Cr | ₹433.39 Cr | ₹355.54 Cr | ₹287.08 Cr |
| Non-current Assets | ₹269.11 Cr | ₹198.01 Cr | ₹142.87 Cr | ₹124.42 Cr |
| Current Assets | ₹276.39 Cr | ₹235.38 Cr | ₹212.67 Cr | ₹162.66 Cr |
| Property, Plant & Equipment | ₹163.8 Cr | ₹142.12 Cr | ₹85.3 Cr | ₹87.59 Cr |
| Inventories | ₹70.28 Cr | ₹51.27 Cr | ₹43.3 Cr | ₹26.99 Cr |
| Trade Receivables | ₹130.88 Cr | ₹81.55 Cr | ₹89.62 Cr | ₹65.87 Cr |
| Cash & Equivalents | ₹2.81 Cr | ₹58.33 Lakh | ₹39.52 Lakh | ₹7.83 Cr |
| Equity (Net Worth) | ₹329.23 Cr | ₹282.43 Cr | ₹262.63 Cr | ₹222.55 Cr |
| Equity Share Capital | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr |
| Borrowings (Non-current) | ₹56.4 Cr | ₹25.34 Cr | ₹74.48 Lakh | ₹2.07 Cr |
| Borrowings (Current) | ₹52.02 Cr | ₹47.82 Cr | ₹31.7 Cr | ₹28.41 Cr |
| Total Debt (computed) | ₹108.43 Cr | ₹73.15 Cr | ₹32.44 Cr | ₹30.48 Cr |
| Current Liabilities | ₹150.01 Cr | ₹118.97 Cr | ₹86.59 Cr | ₹58.29 Cr |
| Total Liabilities | ₹216.27 Cr | ₹150.96 Cr | ₹92.9 Cr | ₹64.53 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹43.32 Cr | ₹35.82 Cr | ₹20.47 Cr | ₹35.29 Cr |
| Investing Cash Flow | -₹70.59 Cr | -₹34.55 Cr | -₹26.82 Cr | -₹27.02 Cr |
| Financing Cash Flow | ₹29.55 Cr | -₹1.08 Cr | -₹1.08 Cr | -₹1.08 Cr |
| Capital Expenditure | ₹89.85 Cr | ₹130.77 Cr | ₹28.52 Cr | ₹31.41 Cr |
| Free Cash Flow (computed) | -₹46.53 Cr | -₹94.95 Cr | -₹8.06 Cr | ₹3.88 Cr |
| Dividends Paid | ₹1.08 Cr | ₹1.08 Cr | ₹1.08 Cr | ₹1.08 Cr |
| Net Change in Cash | ₹2.81 Cr | ₹18.81 Lakh | -₹7.43 Cr | ₹7.18 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹149.23 Cr | ₹127.51 Cr | ₹120.26 Cr | ₹104.19 Cr | ₹94.97 Cr | ₹89.1 Cr | ₹93.48 Cr | ₹90.75 Cr | ₹99.76 Cr | ₹87.95 Cr | ₹80.18 Cr | ₹71.04 Cr |
| Other Income | ₹2.46 Cr | ₹4.61 Cr | ₹2.05 Cr | ₹6.35 Cr | -₹96.56 Lakh | -₹13.19 Lakh | ₹5.12 Cr | ₹5.88 Cr | ₹3.68 Cr | ₹3.68 Cr | ₹3.22 Cr | ₹3.32 Cr |
| Total Income | ₹151.69 Cr | ₹132.12 Cr | ₹122.31 Cr | ₹110.54 Cr | ₹94.01 Cr | ₹88.97 Cr | ₹98.6 Cr | ₹96.64 Cr | ₹103.44 Cr | ₹91.63 Cr | ₹83.4 Cr | ₹74.36 Cr |
| Cost of Materials Consumed | ₹67.3 Cr | ₹62.71 Cr | ₹61.89 Cr | ₹55.4 Cr | ₹51.18 Cr | ₹47.93 Cr | ₹41.8 Cr | ₹41.55 Cr | ₹51.78 Cr | ₹46.07 Cr | ₹40.49 Cr | ₹32.48 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | -₹3.51 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹3.6 Cr | -₹3.19 Cr | -₹4.62 Cr | ₹0 | -₹3.38 Cr | -₹4.4 Cr | ₹2.37 Cr | ₹5.63 Cr | -₹4.47 Cr | -₹4.82 Cr | -₹4.29 Cr | ₹1.45 Cr |
| Employee Benefit Expense | ₹16.96 Cr | ₹17.08 Cr | ₹15.7 Cr | ₹15.76 Cr | ₹14.25 Cr | ₹14.66 Cr | ₹14.72 Cr | ₹11.92 Cr | ₹12.09 Cr | ₹11.52 Cr | ₹10.9 Cr | ₹10.61 Cr |
| Finance Costs | ₹1.01 Cr | ₹1.07 Cr | ₹1.16 Cr | ₹1.22 Cr | ₹97.36 Lakh | ₹60.05 Lakh | ₹31.66 Lakh | ₹44.34 Lakh | ₹48.79 Lakh | ₹27.5 Lakh | ₹36.21 Lakh | ₹24.29 Lakh |
| Depreciation & Amortisation | ₹5.05 Cr | ₹5.18 Cr | ₹5.09 Cr | ₹4.27 Cr | ₹3.32 Cr | ₹3.1 Cr | ₹3.03 Cr | ₹3 Cr | ₹2.92 Cr | ₹2.94 Cr | ₹2.89 Cr | ₹2.86 Cr |
| Other Expenses | ₹39.96 Cr | ₹28.6 Cr | ₹30.14 Cr | ₹25.56 Cr | ₹26.6 Cr | ₹25.81 Cr | ₹23.03 Cr | ₹22.31 Cr | ₹24.54 Cr | ₹21.31 Cr | ₹19.11 Cr | ₹16.64 Cr |
| Total Expenses | ₹133.88 Cr | ₹111.45 Cr | ₹109.35 Cr | ₹98.7 Cr | ₹92.95 Cr | ₹87.7 Cr | ₹85.27 Cr | ₹84.85 Cr | ₹87.35 Cr | ₹77.3 Cr | ₹69.46 Cr | ₹64.28 Cr |
| Profit Before Exceptional Items & Tax | ₹17.81 Cr | ₹20.67 Cr | ₹12.96 Cr | ₹11.84 Cr | ₹1.06 Cr | ₹1.27 Cr | ₹13.33 Cr | ₹11.79 Cr | ₹16.09 Cr | ₹14.33 Cr | ₹13.94 Cr | ₹10.08 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹17.81 Cr | ₹20.67 Cr | ₹12.96 Cr | ₹11.84 Cr | ₹1.06 Cr | ₹1.27 Cr | ₹13.33 Cr | ₹11.79 Cr | ₹16.09 Cr | ₹14.33 Cr | ₹13.94 Cr | ₹10.08 Cr |
| Total Tax Expense | ₹4.33 Cr | ₹4.98 Cr | ₹3.34 Cr | ₹2.6 Cr | ₹51.65 Lakh | -₹1.13 Lakh | ₹3.52 Cr | ₹2.57 Cr | ₹3.77 Cr | ₹4.3 Cr | ₹3.46 Cr | ₹1.58 Cr |
| Net Profit | ₹13.49 Cr | ₹15.69 Cr | ₹9.63 Cr | ₹9.24 Cr | ₹54.37 Lakh | ₹1.28 Cr | ₹9.81 Cr | ₹9.22 Cr | ₹12.32 Cr | ₹10.03 Cr | ₹10.48 Cr | ₹8.51 Cr |
| attributable to Owners | ₹0 | ₹0 | - | ₹0 | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 |
| attributable to NCI | ₹0 | ₹0 | - | ₹0 | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 |
| Other Comprehensive Income | -₹9.32 Lakh | -₹4.22 Lakh | ₹13.78 Lakh | -₹24.47 Lakh | -₹1.14 Lakh | ₹6.22 Lakh | -₹29.99 Lakh | ₹87,000 | -₹50,000 | ₹3.04 Lakh | ₹5.59 Lakh | -₹23.4 Lakh |
| Total Comprehensive Income | ₹13.39 Cr | ₹15.65 Cr | ₹9.76 Cr | ₹9 Cr | ₹53.23 Lakh | ₹1.34 Cr | ₹9.51 Cr | ₹9.23 Cr | ₹12.32 Cr | ₹10.06 Cr | ₹10.53 Cr | ₹8.27 Cr |
| EBITDA (computed) | ₹23.87 Cr | ₹26.93 Cr | ₹19.21 Cr | ₹17.33 Cr | ₹5.35 Cr | ₹4.96 Cr | ₹16.67 Cr | ₹15.24 Cr | ₹19.5 Cr | ₹17.55 Cr | ₹17.19 Cr | ₹13.19 Cr |
| Basic EPS | ₹21.83 | ₹25.40 | ₹15.58 | ₹14.96 | ₹0.88 | ₹2.07 | ₹15.88 | ₹14.92 | ₹19.95 | ₹16.24 | ₹16.96 | ₹13.77 |
| Diluted EPS | ₹21.83 | ₹25.40 | ₹15.58 | ₹14.96 | ₹0.88 | ₹2.07 | ₹15.88 | ₹14.92 | ₹19.95 | ₹16.24 | ₹16.96 | ₹13.77 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹488.77 Cr | ₹359.29 Cr | ₹328.97 Cr | ₹275.05 Cr |
| Other Income | ₹14.85 Cr | ₹9.76 Cr | ₹15.9 Cr | ₹7.61 Cr |
| Total Income | ₹503.63 Cr | ₹369.05 Cr | ₹344.87 Cr | ₹282.66 Cr |
| Cost of Materials Consumed | ₹249.63 Cr | ₹183.8 Cr | ₹166.58 Cr | ₹116.58 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹8.39 Cr | ₹1.36 Cr | -₹12.06 Cr | ₹23.29 Cr |
| Employee Benefit Expense | ₹60.25 Cr | ₹50.71 Cr | ₹41.32 Cr | ₹34.25 Cr |
| Finance Costs | ₹4.4 Cr | ₹2.31 Cr | ₹1.34 Cr | ₹1.2 Cr |
| Depreciation & Amortisation | ₹16.3 Cr | ₹9.27 Cr | ₹8.15 Cr | ₹7.9 Cr |
| Other Expenses | ₹126.81 Cr | ₹97.73 Cr | ₹88.83 Cr | ₹72.85 Cr |
| Total Expenses | ₹449.01 Cr | ₹345.17 Cr | ₹294.17 Cr | ₹256.07 Cr |
| Profit Before Exceptional Items & Tax | ₹54.62 Cr | ₹23.88 Cr | ₹50.71 Cr | ₹26.6 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹54.62 Cr | ₹23.88 Cr | ₹50.71 Cr | ₹26.6 Cr |
| Total Tax Expense | ₹12.99 Cr | ₹5.75 Cr | ₹12.19 Cr | ₹6.48 Cr |
| Net Profit | ₹41.63 Cr | ₹18.13 Cr | ₹38.52 Cr | ₹20.12 Cr |
| Other Comprehensive Income | -₹22.8 Lakh | -₹24.31 Lakh | -₹15.32 Lakh | -₹8.19 Lakh |
| Total Comprehensive Income | ₹41.4 Cr | ₹17.89 Cr | ₹38.37 Cr | ₹20.04 Cr |
| EBITDA (computed) | ₹75.32 Cr | ₹35.46 Cr | ₹60.19 Cr | ₹35.7 Cr |
| Basic EPS | ₹67.39 | ₹29.35 | ₹62.35 | ₹32.56 |
| Diluted EPS | ₹67.39 | ₹29.35 | ₹62.35 | ₹32.56 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹529.63 Cr | ₹425.76 Cr | ₹353.05 Cr | ₹288.11 Cr |
| Non-current Assets | ₹264.38 Cr | ₹195.89 Cr | ₹149.35 Cr | ₹128.92 Cr |
| Current Assets | ₹265.25 Cr | ₹229.87 Cr | ₹203.69 Cr | ₹159.19 Cr |
| Property, Plant & Equipment | ₹143.68 Cr | ₹119.49 Cr | ₹60.01 Cr | ₹59.32 Cr |
| Inventories | ₹67.63 Cr | ₹49.07 Cr | ₹42.6 Cr | ₹26.96 Cr |
| Trade Receivables | ₹125.47 Cr | ₹79.77 Cr | ₹83.13 Cr | ₹65.18 Cr |
| Cash & Equivalents | ₹54.94 Lakh | ₹57.36 Lakh | ₹38.68 Lakh | ₹7.82 Cr |
| Equity (Net Worth) | ₹319.94 Cr | ₹279.61 Cr | ₹262.81 Cr | ₹225.52 Cr |
| Equity Share Capital | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr |
| Borrowings (Non-current) | ₹56.4 Cr | ₹25.34 Cr | ₹74.48 Lakh | ₹2.07 Cr |
| Borrowings (Current) | ₹51.12 Cr | ₹46.84 Cr | ₹31.7 Cr | ₹28.41 Cr |
| Total Debt (computed) | ₹107.53 Cr | ₹72.18 Cr | ₹32.44 Cr | ₹30.48 Cr |
| Current Liabilities | ₹144.03 Cr | ₹114.61 Cr | ₹84.36 Cr | ₹56.65 Cr |
| Total Liabilities | ₹209.69 Cr | ₹146.15 Cr | ₹90.24 Cr | ₹62.59 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹34.73 Cr | ₹17.02 Cr | ₹11.14 Cr | ₹31.89 Cr |
| Investing Cash Flow | -₹64.57 Cr | -₹15.75 Cr | -₹17.49 Cr | -₹23.62 Cr |
| Financing Cash Flow | ₹29.87 Cr | -₹1.08 Cr | -₹1.08 Cr | -₹1.08 Cr |
| Capital Expenditure | ₹89.07 Cr | ₹73.76 Cr | ₹28.01 Cr | ₹29.11 Cr |
| Free Cash Flow (computed) | -₹54.33 Cr | -₹56.75 Cr | -₹16.87 Cr | ₹2.78 Cr |
| Dividends Paid | ₹1.08 Cr | ₹1.08 Cr | ₹1.08 Cr | ₹1.08 Cr |
| Net Change in Cash | ₹2.58 Lakh | ₹18.66 Lakh | -₹7.44 Cr | ₹7.82 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹144.75 Cr | ₹126.33 Cr | ₹116.84 Cr | ₹100.86 Cr | ₹93.02 Cr | ₹86.83 Cr | ₹91.41 Cr | ₹88.03 Cr | ₹95.61 Cr | ₹84.81 Cr | ₹79.44 Cr | ₹69.11 Cr |
| Other Income | ₹2.51 Cr | ₹4.69 Cr | ₹2.41 Cr | ₹6.55 Cr | -₹79.02 Lakh | ₹15.26 Lakh | ₹5.43 Cr | ₹6.27 Cr | ₹4.16 Cr | ₹4.19 Cr | ₹3.76 Cr | ₹3.8 Cr |
| Total Income | ₹147.26 Cr | ₹131.02 Cr | ₹119.25 Cr | ₹107.41 Cr | ₹92.23 Cr | ₹86.98 Cr | ₹96.84 Cr | ₹94.3 Cr | ₹99.77 Cr | ₹89 Cr | ₹83.2 Cr | ₹72.92 Cr |
| Cost of Materials Consumed | ₹68.07 Cr | ₹63.99 Cr | ₹63.55 Cr | ₹55.07 Cr | ₹51.78 Cr | ₹49.82 Cr | ₹41.77 Cr | ₹40.42 Cr | ₹50.01 Cr | ₹45.07 Cr | ₹39.96 Cr | ₹31.54 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | -₹4.05 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹4.12 Cr | ₹0 |
| Changes in Inventories | ₹2.84 Cr | -₹2.48 Cr | -₹5.74 Cr | ₹0 | -₹2.86 Cr | -₹4.73 Cr | ₹3.03 Cr | ₹5.91 Cr | -₹4.52 Cr | -₹5.07 Cr | ₹0 | ₹1.65 Cr |
| Employee Benefit Expense | ₹15.69 Cr | ₹15.72 Cr | ₹14.37 Cr | ₹14.47 Cr | ₹12.94 Cr | ₹13.25 Cr | ₹13.67 Cr | ₹10.85 Cr | ₹10.95 Cr | ₹10.53 Cr | ₹10.05 Cr | ₹9.79 Cr |
| Finance Costs | ₹99.48 Lakh | ₹1.06 Cr | ₹1.15 Cr | ₹1.21 Cr | ₹94.69 Lakh | ₹60.05 Lakh | ₹31.66 Lakh | ₹44.34 Lakh | ₹45.8 Lakh | ₹27.5 Lakh | ₹36.21 Lakh | ₹24.29 Lakh |
| Depreciation & Amortisation | ₹4.24 Cr | ₹4.35 Cr | ₹4.26 Cr | ₹3.45 Cr | ₹2.53 Cr | ₹2.3 Cr | ₹2.3 Cr | ₹2.14 Cr | ₹2.06 Cr | ₹2.07 Cr | ₹2.02 Cr | ₹2 Cr |
| Other Expenses | ₹40.55 Cr | ₹29 Cr | ₹31 Cr | ₹27.55 Cr | ₹27.25 Cr | ₹24.93 Cr | ₹22.32 Cr | ₹24.53 Cr | ₹26.57 Cr | ₹23.33 Cr | ₹20.42 Cr | ₹18.53 Cr |
| Total Expenses | ₹132.38 Cr | ₹111.65 Cr | ₹108.59 Cr | ₹97.7 Cr | ₹92.59 Cr | ₹86.17 Cr | ₹83.41 Cr | ₹84.3 Cr | ₹85.54 Cr | ₹76.21 Cr | ₹68.69 Cr | ₹63.75 Cr |
| Profit Before Exceptional Items & Tax | ₹14.88 Cr | ₹19.37 Cr | ₹10.66 Cr | ₹9.71 Cr | -₹36.03 Lakh | ₹81.11 Lakh | ₹13.43 Cr | ₹10 Cr | ₹14.24 Cr | ₹12.8 Cr | ₹14.52 Cr | ₹9.16 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹14.88 Cr | ₹19.37 Cr | ₹10.66 Cr | ₹9.71 Cr | -₹36.03 Lakh | ₹81.11 Lakh | ₹13.43 Cr | ₹10 Cr | ₹14.24 Cr | ₹12.8 Cr | ₹14.52 Cr | ₹9.16 Cr |
| Total Tax Expense | ₹3.52 Cr | ₹4.64 Cr | ₹2.76 Cr | ₹2.07 Cr | ₹16.02 Lakh | ₹2.83 Lakh | ₹3.39 Cr | ₹2.18 Cr | ₹3.39 Cr | ₹3.9 Cr | ₹3.55 Cr | ₹1.36 Cr |
| Net Profit | ₹11.35 Cr | ₹14.74 Cr | ₹7.9 Cr | ₹7.64 Cr | -₹52.05 Lakh | ₹78.28 Lakh | ₹10.04 Cr | ₹7.83 Cr | ₹10.85 Cr | ₹8.9 Cr | ₹10.97 Cr | ₹7.81 Cr |
| Other Comprehensive Income | -₹7.39 Lakh | -₹4.39 Lakh | ₹13.1 Lakh | -₹24.11 Lakh | -₹1.27 Lakh | ₹5.98 Lakh | -₹29.34 Lakh | ₹33,000 | -₹16,000 | ₹2.66 Lakh | ₹5.34 Lakh | -₹23.16 Lakh |
| Total Comprehensive Income | ₹11.28 Cr | ₹14.69 Cr | ₹8.03 Cr | ₹7.4 Cr | -₹53.32 Lakh | ₹84.26 Lakh | ₹9.75 Cr | ₹7.83 Cr | ₹10.85 Cr | ₹8.92 Cr | ₹11.02 Cr | ₹7.57 Cr |
| EBITDA (computed) | ₹20.11 Cr | ₹24.78 Cr | ₹16.08 Cr | ₹14.37 Cr | ₹3.12 Cr | ₹3.71 Cr | ₹16.05 Cr | ₹12.59 Cr | ₹16.76 Cr | ₹15.14 Cr | ₹16.89 Cr | ₹11.4 Cr |
| Basic EPS | ₹18.38 | ₹23.85 | ₹12.78 | ₹12.37 | ₹-0.84 | ₹1.27 | ₹16.26 | ₹12.67 | ₹17.56 | ₹14.40 | ₹17.76 | ₹12.63 |
| Diluted EPS | ₹18.38 | ₹23.85 | ₹12.78 | ₹12.37 | ₹-0.84 | ₹1.27 | ₹16.26 | ₹12.67 | ₹17.56 | ₹14.40 | ₹17.76 | ₹12.63 |
Shareholding Pattern of Ngl Fine-Chem Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 72.74%, foreign institutional investors hold 0.03%, retail and other public shareholders hold 27.24% of Ngl Fine-Chem Limited. The company had 12,516 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% |
| Public | 27.26% | 27.26% | 27.26% | 27.26% | 27.26% | 27.26% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Promoters | 72.74% | 72.74% | 72.74% | 73.53% |
| Public | 27.26% | 27.26% | 27.26% | 26.47% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | -0.79 | - |
Board & Governance of Ngl Fine-Chem Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Ngl Fine-Chem Limited has 6 directors - 3 independent and 2 executive. The board is chaired by DHANANJAY MUNGALE.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| RAHUL NACHANE | Executive Director · MD | 1993-01-04 | 1 |
| RAJESH LAWANDE | Executive Director | 2015-06-01 | 1 |
| AJITA NACHANE | Non-Executive - Non Independent Director | 2014-09-15 | 1 |
| DHANANJAY MUNGALE | Non-Executive - Independent Director · Chairperson | 2024-03-18 | 2 |
| SUDHIR DEO | Non-Executive - Independent Director | 2025-05-22 | 2 |
| SARALA MENON | Non-Executive - Independent Director | 2021-12-14 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | DHANANJAY MUNGALE (Chairperson), RAJESH LAWANDE, SUDHIR DEO, SARALA MENON |
| Nomination and remuneration committee | SARALA MENON (Chairperson), AJITA NACHANE, DHANANJAY MUNGALE |
| Stakeholders Relationship Committee | SARALA MENON (Chairperson), RAHUL NACHANE, AJITA NACHANE |
| Risk Management Committee | RAHUL NACHANE (Chairperson), RAJESH LAWANDE, AJITA NACHANE, SUDHIR DEO |
| Corporate Social Responsibility Committee | SARALA MENON (Chairperson), RAJESH LAWANDE, AJITA NACHANE |
| ADMINISTRATIVE COMMITTEE | RAHUL NACHANE (Chairperson), RAJESH LAWANDE, AJITA NACHANE |
Group Structure of Ngl Fine-Chem Limited
Ngl Fine-Chem Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Ngl Fine-Chem Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Macrotech Polychem Private Limited | U24100MH2004PTC145189 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Ngl Fine-Chem Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2023 | Hdfc Bank Limited | ₹25 Lakh | Open |
| 02 Aug 2022 | Others | ₹50.5 Cr | Open |
| 07 Dec 2015 | Hdfc Bank Limited | ₹67 Cr | Open |
| 10 Mar 2022 | Hdfc Bank Limited | ₹30 Lakh | Satisfied |
| 30 Aug 2021 | Hdfc Bank Limited | ₹19 Lakh | Satisfied |
Total charge records: 30 View all charges
Employees and EPFO Compliance at Ngl Fine-Chem Limited
Ngl Fine-Chem Limited has a workforce of 363 employees as of Apr 08, 2024.
Employee Count & EPFO Data of Ngl Fine-Chem Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Ngl Fine-Chem Limited
GSTIN & GST Filing Data of Ngl Fine-Chem Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Ngl Fine-Chem Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Ngl Fine-Chem Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Ngl Fine-Chem Limited
MSME Payment Delays by Ngl Fine-Chem Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Ngl Fine-Chem Limited
Subsidiaries & Group Companies of Ngl Fine-Chem Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ngl Fine-Chem Limited with ownership details.
MCA Filings & Documents of Ngl Fine-Chem Limited
MCA Filings & Documents of Ngl Fine-Chem Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Ngl Fine-Chem Limited
Recent News on Ngl Fine-Chem Limited
Frequently Asked Questions about Ngl Fine-Chem Limited
Ngl Fine-Chem Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 18 December 1981 (45+ years old) and is registered under CIN L24110MH1981PLC025884. Listed on BSE: 524774. The company has 363 employees.
Ngl Fine-Chem Limited reported revenue of ₹376.89 Cr for FY 2025 (up 7.00% YoY).
The current directors of Ngl Fine-Chem Limited are:
- Ajita Rahul Nachane
- Dhananjay Narendra Mungale
- Rahul Jayant Nachane
- Pallavi Satish Pednekar
- Rajesh Narayan Lawande
- Sudhir Ramchandra Deo
- Sarala Menon
The primary industry of Ngl Fine-Chem Limited is pharma. The company specifically operates in animal pharmaceuticals and healthcare. The company is currently active in this sector.
Yes. Ngl Fine-Chem Limited is listed on BSE with code 524774.
Ngl Fine-Chem Limited can be reached at the registered office: 301 E Square Subhash Road Vile Parle East, Mumbai, Maharashtra, India – 400057, or through the website nglfinechem.com.